Nicolas Rodondi Selected Research

Cysteine (L-Cysteine)

10/2021	Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
12/2017	Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Rodondi Research Topics

Disease

45	Hypothyroidism 04/2024 - 11/2005
34	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2005
28	Acute Coronary Syndrome 10/2021 - 06/2008
23	Stroke (Strokes) 02/2024 - 11/2005
23	Myocardial Infarction 11/2023 - 04/2006
18	Hemorrhage 12/2023 - 08/2012
17	Atrial Fibrillation 01/2024 - 01/2020
17	Hypertension (High Blood Pressure) 12/2023 - 04/2006
17	Coronary Disease (Coronary Heart Disease) 12/2023 - 11/2005
16	Heart Failure 06/2023 - 11/2005
14	Neoplasms (Cancer) 01/2024 - 12/2010
14	Venous Thromboembolism 09/2023 - 01/2015
14	Atherosclerosis 01/2023 - 11/2006
14	Hyperthyroidism 11/2021 - 04/2007
12	Frailty 01/2023 - 01/2017
10	Malnutrition (Nutritional Deficiencies) 01/2023 - 01/2019
9	ST Elevation Myocardial Infarction 06/2023 - 06/2015
9	Chronic Disease (Chronic Diseases) 01/2023 - 04/2009
9	Diabetes Mellitus 01/2020 - 04/2006
7	Death (Near-Death Experience) 11/2023 - 06/2015
7	Inflammation (Inflammations) 01/2023 - 07/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 08/2013
6	Pneumonia (Pneumonitis) 12/2023 - 06/2014
6	Anemia 01/2022 - 01/2015
6	Pulmonary Embolism 09/2019 - 01/2014
5	Transient Ischemic Attack 02/2024 - 08/2012
4	Drug-Related Side Effects and Adverse Reactions 08/2023 - 11/2018
4	Chronic Renal Insufficiency 01/2022 - 11/2016
4	Dyslipidemias (Dyslipidemia) 03/2020 - 04/2006
4	Body Weight (Weight, Body) 02/2017 - 04/2002
3	Thrombosis (Thrombus) 01/2024 - 01/2018
3	Fibrosis (Cirrhosis) 08/2023 - 03/2012
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2021
3	Peripheral Arterial Disease 01/2023 - 11/2005
3	Critical Illness (Critically Ill) 03/2022 - 01/2019
3	Chest Pain (Chest Pains) 03/2021 - 02/2016
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2021 - 01/2016
3	Fatigue 01/2020 - 02/2017
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2018 - 03/2016
3	Carotid Artery Diseases 01/2018 - 04/2007
3	Hypercholesterolemia 03/2016 - 04/2002
2	Hemorrhagic Stroke 02/2024 - 02/2008
2	Ischemic Stroke 01/2024 - 12/2022
2	Portal Hypertension 08/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

37	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2024 - 11/2005
28	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 02/2009
25	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2023 - 11/2005
21	Thyroid HormonesIBA 04/2024 - 04/2007
21	LipidsIBA 02/2024 - 04/2002
17	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2013
14	LDL CholesterolIBA 02/2024 - 03/2010
13	C-Reactive ProteinIBA 01/2023 - 03/2010
12	omega-Chloroacetophenone (Mace)IBA 11/2023 - 02/2017
10	AnticoagulantsIBA 12/2023 - 08/2012
7	Ezetimibe (Zetia)FDA Link 02/2024 - 01/2016
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2002
7	CreatinineIBA 01/2022 - 04/2007
5	oxidized low density lipoproteinIBA 02/2024 - 01/2016
5	Vitamin K FDA Link 01/2024 - 01/2015
5	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 03/2018
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 01/2005
5	PCSK9 InhibitorsIBA 01/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
4	Triglycerides (Triacylglycerol)IBA 02/2024 - 04/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 06/2014
4	trimethyloxamine (trimethylamine N-oxide)IBA 01/2023 - 03/2017
4	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2017
4	Troponin T (Troponin T1)IBA 10/2021 - 09/2016
4	Interleukin-6 (Interleukin 6)IBA 03/2021 - 03/2010
4	SubtilisinIBA 01/2021 - 01/2016
4	Hormones (Hormone)IBA 02/2018 - 08/2012
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2024 - 02/2021
3	Docosahexaenoic AcidsIBA 01/2024 - 02/2021
3	Eicosapentaenoic AcidIBA 01/2024 - 02/2021
3	docosapentaenoic acidIBA 01/2024 - 02/2021
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2024 - 02/2021
3	Insulin (Novolin)FDA Link 12/2023 - 04/2002
3	Prednisone (Sone)FDA LinkGeneric 12/2023 - 04/2015
3	AntibodiesIBA 10/2023 - 09/2014
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
3	Cystatin CIBA 01/2022 - 04/2007
3	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021 - 01/2016
3	HDL CholesterolIBA 07/2019 - 04/2002
3	CholesterolIBA 03/2016 - 04/2002
3	Adenosine Triphosphate (ATP)IBA 06/2012 - 02/2009
2	Proprotein Convertase 9IBA 02/2024 - 03/2016
2	Fibric Acids (Fibrates)IBA 02/2024 - 03/2020
2	Iodide Peroxidase (Deiodinase)IBA 10/2023 - 09/2014
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 12/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2023 - 01/2016

Therapy/Procedure

43	Therapeutics 04/2024 - 04/2002
13	Polypharmacy 08/2023 - 01/2015
11	Nutritional Support (Artificial Feeding) 01/2023 - 01/2019
10	Secondary Prevention 01/2024 - 11/2006
7	Percutaneous Coronary Intervention 06/2023 - 01/2016
6	Length of Stay 01/2021 - 04/2006
5	Cardiac Rehabilitation 01/2023 - 01/2016
3	Activities of Daily Living (ADL) 01/2021 - 09/2012
2	Deprescriptions 05/2024 - 12/2022
2	Continuity of Patient Care 01/2023 - 03/2008